These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 15811630)
21. Distinctive activities of DNA polymerases during human DNA replication. Rytkönen AK; Vaara M; Nethanel T; Kaufmann G; Sormunen R; Läärä E; Nasheuer HP; Rahmeh A; Lee MY; Syväoja JE; Pospiech H FEBS J; 2006 Jul; 273(13):2984-3001. PubMed ID: 16762037 [TBL] [Abstract][Full Text] [Related]
22. DNA polymerase kappa from Trypanosoma cruzi localizes to the mitochondria, bypasses 8-oxoguanine lesions and performs DNA synthesis in a recombination intermediate. Rajão MA; Passos-Silva DG; DaRocha WD; Franco GR; Macedo AM; Pena SD; Teixeira SM; Machado CR Mol Microbiol; 2009 Jan; 71(1):185-97. PubMed ID: 19007414 [TBL] [Abstract][Full Text] [Related]
23. Down-regulation of DNA polymerases kappa, eta, iota, and zeta in human lung, stomach, and colorectal cancers. Pan Q; Fang Y; Xu Y; Zhang K; Hu X Cancer Lett; 2005 Jan; 217(2):139-47. PubMed ID: 15617831 [TBL] [Abstract][Full Text] [Related]
24. Polymerase eta mRNA expression predicts survival of non-small cell lung cancer patients treated with platinum-based chemotherapy. Ceppi P; Novello S; Cambieri A; Longo M; Monica V; Lo Iacono M; Giaj-Levra M; Saviozzi S; Volante M; Papotti M; Scagliotti G Clin Cancer Res; 2009 Feb; 15(3):1039-45. PubMed ID: 19188177 [TBL] [Abstract][Full Text] [Related]
25. DNA polymerase eta: A potential pharmacological target for cancer therapy. Saha P; Mandal T; Talukdar AD; Kumar D; Kumar S; Tripathi PP; Wang QE; Srivastava AK J Cell Physiol; 2021 Jun; 236(6):4106-4120. PubMed ID: 33184862 [TBL] [Abstract][Full Text] [Related]
26. Miscoding properties of 2'-deoxyinosine, a nitric oxide-derived DNA Adduct, during translesion synthesis catalyzed by human DNA polymerases. Yasui M; Suenaga E; Koyama N; Masutani C; Hanaoka F; Gruz P; Shibutani S; Nohmi T; Hayashi M; Honma M J Mol Biol; 2008 Apr; 377(4):1015-23. PubMed ID: 18304575 [TBL] [Abstract][Full Text] [Related]
27. DNA polymerases for translesion DNA synthesis: enzyme purification and mouse models for studying their function. Fischhaber PL; McDaniel LD; Friedberg EC Methods Enzymol; 2006; 408():355-78. PubMed ID: 16793380 [TBL] [Abstract][Full Text] [Related]
28. Expression of an X-family DNA polymerase, pol lambda, in the respiratory epithelium of non-small cell lung cancer patients with habitual smoking. Ohba T; Kometani T; Shoji F; Yano T; Yoshino I; Taguchi K; Kuraoka I; Oda S; Maehara Y Mutat Res; 2009; 677(1-2):66-71. PubMed ID: 19467344 [TBL] [Abstract][Full Text] [Related]
29. The effect of oxidative metabolism on spontaneous Pol zeta-dependent translesion synthesis in Saccharomyces cerevisiae. Minesinger BK; Abdulovic AL; Ou TM; Jinks-Robertson S DNA Repair (Amst); 2006 Feb; 5(2):226-34. PubMed ID: 16290107 [TBL] [Abstract][Full Text] [Related]
30. Conformational changes during normal and error-prone incorporation of nucleotides by a Y-family DNA polymerase detected by 2-aminopurine fluorescence. DeLucia AM; Grindley ND; Joyce CM Biochemistry; 2007 Sep; 46(38):10790-803. PubMed ID: 17725324 [TBL] [Abstract][Full Text] [Related]
31. Homology modeling of four Y-family, lesion-bypass DNA polymerases: the case that E. coli Pol IV and human Pol kappa are orthologs, and E. coli Pol V and human Pol eta are orthologs. Lee CH; Chandani S; Loechler EL J Mol Graph Model; 2006 Sep; 25(1):87-102. PubMed ID: 16386932 [TBL] [Abstract][Full Text] [Related]
32. Overproduction of Escherichia coli DNA polymerase DinB (Pol IV) inhibits replication fork progression and is lethal. Uchida K; Furukohri A; Shinozaki Y; Mori T; Ogawara D; Kanaya S; Nohmi T; Maki H; Akiyama M Mol Microbiol; 2008 Nov; 70(3):608-22. PubMed ID: 18761688 [TBL] [Abstract][Full Text] [Related]
33. Characterization of promoter regulatory elements involved in downexpression of the DNA polymerase kappa in colorectal cancer. Lemée F; Bavoux C; Pillaire MJ; Bieth A; Machado CR; Pena SD; Guimbaud R; Selves J; Hoffmann JS; Cazaux C Oncogene; 2007 May; 26(23):3387-94. PubMed ID: 17099721 [TBL] [Abstract][Full Text] [Related]
34. Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers. Goto T; Takano M; Sakamoto M; Kondo A; Hirata J; Kita T; Tsuda H; Tenjin Y; Kikuchi Y Oncol Rep; 2006 May; 15(5):1265-71. PubMed ID: 16596196 [TBL] [Abstract][Full Text] [Related]
35. Distribution and roles of X-family DNA polymerases in eukaryotes. Uchiyama Y; Takeuchi R; Kodera H; Sakaguchi K Biochimie; 2009 Feb; 91(2):165-70. PubMed ID: 18706967 [TBL] [Abstract][Full Text] [Related]
36. How are specialized (low-fidelity) eukaryotic polymerases selected and switched with high-fidelity polymerases during translesion DNA synthesis? Fischhaber PL; Friedberg EC DNA Repair (Amst); 2005 Feb; 4(2):279-83. PubMed ID: 15590336 [TBL] [Abstract][Full Text] [Related]
37. DNA polymerases and human disease. Loeb LA; Monnat RJ Nat Rev Genet; 2008 Aug; 9(8):594-604. PubMed ID: 18626473 [TBL] [Abstract][Full Text] [Related]
38. Cholesterol hemisuccinate: a selective inhibitor of family X DNA polymerases. Ishimaru C; Kuriyama I; Shimazaki N; Koiwai O; Sakaguchi K; Kato I; Yoshida H; Mizushina Y Biochem Biophys Res Commun; 2007 Mar; 354(2):619-25. PubMed ID: 17241613 [TBL] [Abstract][Full Text] [Related]
39. Identification of a strand-related bias in the PCNA-mediated bypass of spontaneous lesions by yeast Poleta. Abdulovic AL; Minesinger BK; Jinks-Robertson S DNA Repair (Amst); 2007 Sep; 6(9):1307-18. PubMed ID: 17442629 [TBL] [Abstract][Full Text] [Related]
40. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta. Alt A; Lammens K; Chiocchini C; Lammens A; Pieck JC; Kuch D; Hopfner KP; Carell T Science; 2007 Nov; 318(5852):967-70. PubMed ID: 17991862 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]